Skip to main content
OpenTrials

Clinical trial condition

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)

Explore clinical trials studying PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS) trial results

Active, Not Recruiting

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

NCT04980872

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital Abnormalities, +15 more
Locations
  • Children's Healthcare of Atlanta - Egleston Hospital ( Site 0107) Atlanta, Georgia, United States
  • Boston Children's Hospital ( Site 0089) Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center-Hematology ( Site 0102) Cincinnati, Ohio, United States
  • Texas Children's Hospital ( Site 0104) Houston, Texas, United States
View Trial Details

Related conditions